Antibiotic resistance

End of the antibiotic era?

  • This would mean people start dying younger due to infection because bacteria have become resistant to antibiotics

  • This means common antibiotics are unable to be used and more toxic antibiotics must be given as last line.

 

Effects of antimicrobial agents on bacteria

  • Bacteriostatic- growth inhibition

  • Bactericidal - cell killing

 

What are the four main classes of antibiotic targets?

  • Cell wall synthesis

  • Protein synthesis

  • Metabolic pathways

  • Nucleic acid synthesis

 

Reasons for resistance to antibiotics

Natural:

  • Lack target structure

  • Impermeable to antibiotic

  • Lactobacilli are intrinsically resistant to vancomycin

Acquired:

  • Enzymic inactivation

  • Modification of target

  • Acquisition of Efflux mechanism to pump out antibiotics

Different antibiotics target different 
cellular sites/ processes 
Cell wall s 
Cycloserine 
Va ncomycin 
Bacitracin 
Pe nicillins 
thesis 
DNA ase 
Nalidixic acid 
Quinolones 
Ciprofloxacin 
Novobiocin 
THF 
DHF 
rase 
RNA elongation 
Actinomyci n 
Ribosomes 
DNA-directed RNA 01 
Rifampin 
Streptovaricins 
Protein synthesis 
(50S inhibitors) 
Monobactams 
Carbapenems 
Folic acid nwtabolism 
Trimethoprim 
Sulfonamides 
mRNA 
30 
30 
Cytoplasnic rTErrbrane 
structure and function 
Polymyxins 
Daptomycin 
PABA 
0 2012 Pearson Educatön, Inc. 
Cytoplaynic 
membrane 
30 
Lipid 
bios thesis 
Platensimycin 
Cell wall 
Erythromycin (macrolides) 
Chloramphenicol 
Clindamycin 
Lincomycin 
Protein synthesis 
(30S inhibitors) 
Tetracyclines 
Spectinomycin 
Stre ptomycin 
Ge nta micin 
Ka mycin 
Amikacin 
Nitrofurans 
Proteins thesis 
tRIÅ) 
Mupirocin 
Puromycin 
8

Antibiotics- 
Gram-negative 
Mycobacteria 
bacteria 
Tobramycin 
spectrum of activity 
Gram-positive 
bacteria 
Penicillins 
Chlamydias 
Isoniazid 
Sulfonamides 
Cephalosporins 
Streptomycin 
Tetracyclines 
Polymyxins 
Figure 13-1 Microbiology,6/e 
@ 2005 John Wiley & Sons 
Rickettsias 
9 Antibiotic resistance:

  • When treating patient with antibiotic it is both pathogen and microbiota of body (oral cavity, nasal and small intestine) which are exposed

  • Antibiotic resistance is the acquired ability of microorganism to resist the effects of chemotherapeutic agent which it is normally sensitive to

 

Why does antibiotic resistance develop?

  • Selection pressure

  • Transfer of resistant genes (species to species; genus to genus)

  • Rapid cell division

  • Antibiotic selection pressure 
norrnal bacterium dead bacterium 
resistant bacterium

Causes of antibiotic resistance:

  • Overuse of antibiotics

  • Improper disposal

  • Travelling (spreading resistant bacteria)

  • Lack of hand washing

 

  • Antibiotic resistance increases with

    • Antibiotic use

    •  time

Biochemical mechanisms of antibiotic resistance

  • Overproduction/ alternation of target

  • Alternative pathway

  • Decreased influx/ increased efflux

  • Drug modification

  • Drug destruction

How do microorganisms acquire the ability to become resistant to antibiotics?

Horizontal gene transfer:

  • Transformation

    • one mode of horizontal gene transfer (HGT) in bacteria, wherein extracellular naked DNA is taken up by cells that have developed genetic competence

  • Conjugation

    • a gene transfer process in which a recipient bacterium receives DNA from a donor bacterium by cell-to-cell contact through conjugative pili. Conjugation is mediated by certain plasmids or transposons.

  • Transduction

    • Transduction is the process by which foreign DNA is introduced into a cell by a virus or viral vector.

    • An example is the viral transfer of DNA from one bacterium to another

What are biofilms?

  • Bacteria which are much less susceptible to antimicrobials than planktonic bacteria

Antimicrobial stewardship:

  • Don't start antibiotics id bacterial infection is not evident

  • Use local guidelines for antibiotic treatment

  • Document antibiotic use on drug chart/medical notes

  • Obtain cultures before giving out (use professional judgement)

  • Single dose antibiotics for surgical prophylaxis

  • Review need for antibiotics by 48 hours

  • Figure I: Antimicrobial Stewardship (AMS) — Treatment algorithm 
ANTIMICROBIAL STEWARDSHIP 
Treatment algorithm 
Start Smart 
DO NOT START ANTIBIOTICS IN 
THE ABSENCE OF CLINICAL 
EVIDENCE OF BACTERIAL 
INFECTION 
Then Focus 
CLINICAL REVIEW & DECISION 
AT 48-72 HOURS 
Clinical review, check microbiology and make 
a clear plan. Document this decision 
2. 
3. 
4. 
5. 
6. 
Take thorough drug allergy history 
Initiate prompt effective antibiotic treatment 
within one hour of diagnosis (or as soon as 
possible) in patients with severe sepsis or 
life-threatening infectionsa 
Comply with local antimicrobial prescribing 
guidance 
Document clinical indication (and disease 
severity if appropriate), doseß and route* 
on drug chart and in clinical notes 
Include review/stop date or duration 
Obtain cultures prior to commencing 
therapy where possible (but do not delay 
therapy) 
2. 
3. 
4. 
5. 
STOP 
IV to oral switch 
Change antibiotic 
Continue 
OPAT* 
Document 
Decision & Next 
Review Date or 
Stop Date 
DOCUMENT ALL DECISIONS 
o In sepsis pÖert safety 
Ottp england nhs conterWupIoads,QO 
to weigw.ge in children refer to local formu.•y BNFC 
QJse "propriate route in ine wit' seve%ieri factors 
Parenteral Theroy 
Advocating patient safety and auditing of antimicrobial stewardship in hospitals should be based around the principles stated in thi 
AMS algorithm. Examples of audit tools are shared in Appendix I 
https://www.gov.uk

  • Figure 2: Antimicrobial Stewardship (AMS) — Surgical prophylaxis algorithm 
ANTIMICROBIAL STEWARDSHIP 
Surgical prophylaxis algorithm 
Clean surgery 
Clean contaminated 
Involving placement of 
surgery 
a prosthesis or implant 
Surgical Prophylaxis 
ONE DOSE*I 
Contaminated surgery 
Within 60 minutes before knife to skin2 
Redose for long surgical procedures 
Intraoperative redosing is needed to ensure adequate serum and tissue concentrations of the antimicrobial 
if the duration of the procedure exceeds two half-lives of the antimicrobial or there is excessive blood loss 
(i.e., >1500 mL in adults3 or >25mVkg in children). A treatment course of antibiotics may also need to be 
given (in addition to appropriate prophylaxis) in cases of dirty surgery or infected wounds3. The appropriate 
use and choice of antibiotics should be discussed with infection specialists for each case. 
DOCUMENT ALL DECISIONS 
References: 
1. NICE cir-iCal %ideine 74: •.r•cal site infection — Prevertion and of sur#al site infection 
http nice oro 
2 Workl aliance for Patiert Safety. WHO sugical safety check'st 2008 
Ntp resources,'SSSL Checkist final-Jun080df7ua=1 
3. Bratzier DW, De'nger EP, Olsen KM etal_ (2013). CiNcal practice *idérws in svwy_ Am' Heath 
syst Pharm 2013: 70(3): 195-283 
Advocating patient safety and auditing of antimicrobial stewardship in hospitals should be based around the principles stated in this 
AMS algorithm. Examples of audit tools are shared in Appendix 1. Deviations from the NICE guideline should be evidence based, 
with prolonged prophylaxis needing evidence of benefit. 
30 
https://www.gov.uk